Alpha Therapeutic’s Fluosol
Executive Summary
Intravascular perfluorochemical emulsion was listed by FDA as Fluosol-DA under the head "Biological Product Licenses Issued" in the agency's "January 1990-Prepared Report on NDA Approvals" ("The Pink Sheet" March 26, p. 13). The blood substitute is a drug product that received NDA approval on Dec. 26 ("The Pink Sheet" Jan. 8, p. 8). The DA was dropped from the tradename several years ago.